Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused by <i>Pseudomonas aeruginosa</i>

Abstract

Nebulization and intravenous infusion of ceftazidime and amikacin provide similar efficiency for treating ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Nebulization is efficient against intermediate strains and may prevent per-treatment acquisition of antibiotic resistance.